Recruitment of β-arrestin2 to the dopamine D2 receptor: Insights into anti-psychotic and anti-parkinsonian drug receptor signaling
- 8 April 2008
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 54 (8) , 1215-1222
- https://doi.org/10.1016/j.neuropharm.2008.03.015
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signalingProceedings of the National Academy of Sciences, 2007
- β-Arrestin-biased ligands at seven-transmembrane receptorsTrends in Pharmacological Sciences, 2007
- Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor β-Arrestin Recruitment and Signaling through GαThe Journal of Pharmacology and Experimental Therapeutics, 2007
- The Akt–GSK-3 signaling cascade in the actions of dopaminePublished by Elsevier ,2007
- Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light outputProtein Engineering, Design and Selection, 2006
- High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based β-Arrestin2 Recruitment AssaySLAS Discovery, 2005
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Functional Selectivity of D2 Receptor Ligands in a Chinese Hamster Ovary hD2L Cell Line: Evidence for Induction of Ligand-Specific Receptor StatesMolecular Pharmacology, 2004
- Development of a BRET2 Screening Assay Using β-Arrestin 2 MutantsSLAS Discovery, 2004
- A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applicationsNature Biotechnology, 2002